Apple's AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings

Interested in Apple Inc.? Here are five stocks we like better.

Apple's so-called 'toll booth' AI thesis remains unproven since the company currently pays other firms for AI models rather than monetizing its own ecosystem.

KeyBanc's rare Underweight downgrade warns that rising component costs have already lifted Mac and iPad prices and could soon slow iPhone revenue growth in fiscal 2027.

Trading near 36 times forward earnings with China sales softening, Apple's July 30 report must show AI is boosting Services or margins to justify its valuation.

Apple (NASDAQ: AAPL) has rallied sharply since late June, keeping the stock near record territory as investors look ahead to the company's Q3 2026 earnings report, expected on June 30. At first glance, the setup heading into that report appears relatively straightforward.

Analysts have been busy raising price targets, the stock has been hitting highs, and the market appears to be leaning into the thesis that Apple's ecosystem and pricing power will deliver the goods as its AI strategy ramps up.

However, not everyone is convinced that this bet is safe. A growing number of voices are questioning whether Wall Street has gotten ahead of itself, pricing in an AI-driven future that Apple hasn't demonstrated it can deliver, while ignoring a set of very real, near-term cost pressures.

That gap between the optimism priced into the stock and the caution running through some of the underlying analysis is becoming harder to ignore, and this month's earnings report threatens to widen it further.

→ These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending

Much of the bull case for Apple's AI positioning rests on what's often called the "toll booth" thesis: the idea that Apple doesn't need to build the best AI model because it owns the device and platform through which people will access AI, and can therefore extract value regardless of which model wins. It is a compelling argument, and one we have recently covered through the lens of Apple's agentic AI opportunity.

The trouble is that the evidence for it actually working in practice is thin. Rather than monetizing AI usage directly, Apple is currently paying other companies for the AI models running inside its own ecosystem. That sounds more like a cost center than a toll booth.

Until that dynamic flips, and until Apple demonstrates it can turn its AI features into meaningful revenue, the thesis remains more theoretical than proven. Investors betting on it are, for now, betting on potential rather than results.

While the AI upside remains speculative, the cost side of Apple's story is anything but. Surging NAND and DRAM prices have already forced the company to raise prices across its Mac and iPad lineups, and speculation continues to build that iPhone pricing will follow suit later this year.

The KeyBanc team made this exact point earlier this week, as they downgraded Apple to Underweight—a rare, but worrying, outright bearish stance. The firm's analysts pointed to iPad price increases of $100 to $200 and MacBook increases of up to $300, arguing that products at this level tend to see demand fall by more than the size of the price increase. Their bigger worry is what happens when that same dynamic hits the iPhone. To give a sense of what that could look like, KeyBanc is expecting iPhone revenue growth to slow sharply in fiscal 2027, coming in well below the broader consensus.

Adding to the pressure, KeyBanc also flagged that U.S. carriers may pull back on device subsidies as costs rise, which would likely extend how long customers hold onto their phones before upgrading and could complicate Apple's growth story both domestically and internationally.

Then there's the valuation itself. Apple currently trades at around 36 times forward earnings, which is one of the highest multiples among its mega-cap technology peers. That feels like a lot to pay for a company that doesn't yet have a clear AI-driven catalyst for either growth or margin expansion.

Add in a China business facing both slowing sales and margin pressures, and the risk-reward balance starts to look increasingly skewed to the downside.